Healthcare companies rose as traders sought out sectors that are less vulnerable to swings in economic growth and inflation prospects.

Shares of vTv Therapeutics rose after the Food and Drug Administration lifted a clinical hold on its diabetes treatment program. Bayer has won U.S. Food and Drug Administration priority review for ...

as an add-on to standard care for the treatment of adults with stage 3 and 4 CKD associated with type 2 diabetes. Bayer has made digital health a core part of its offering to patients, alongside ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

Bayer and Merck & Co’s heart failure drug ... Meanwhile, AstraZeneca’s Farxiga (dapagliflozin), originally a diabetes drug, was approved in the US last year in heart failure with reduced ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

In a report released yesterday, Matt Miksic from Barclays reiterated a Buy rating on Tandem Diabetes Care (TNDM – Research Report), with a ...

This new study has found perceived discrimination in health care leads to delayed visits, especially among younger and ...

Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...

The Discovery Health Diabetes Shared-Value Programme is designed to align with the goals of the patient, medical practitioner ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...